European Unified Registries for Heart Care Evaluation and Randomised Trials
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
- 试验地点
- 103
- 主要终点
- Adherence to ESC Quality indicators (STEMI patients reperfused)
研究概览
简要总结
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥18 years of age.
- •Males and females at birth.
- •At least one of the following clinical conditions:
- •Hospitalization for Acute Coronary Syndrome (ACS)
- •Heart failure (HF, outpatients, and/or inpatients)
- •Atrial fibrillation (A Fib, outpatients and/or inpatients)
- •Signed informed consent for the study and for privacy.
排除标准
- •patients who do not sign the consent to participate in the project and/or Privacy
结局指标
主要结局
Adherence to ESC Quality indicators (STEMI patients reperfused)
时间窗: From enrollment to 12 months follow-up
Proportion of patients with STEMI reperfused among those eligible (onset of symptoms to diagnosis \<12 hours)
Adherence to ESC Quality indicators (STEMI patients reperfused <90 min)
时间窗: From enrollment to 12 months follow-up
Proportion of patients with STEMI who receive timely reperfusion with PCI (wire crossing) within 90 minutes from initial diagnostic ECG
Adherence to ESC Quality indicators (coronary angiography in NSTEMI patients within 24 hours)
时间窗: From enrollment to 12 months follow-up
Rate of NSTEMI patients who receive invasive within 24 hours from their diagnosis
Adherence to ESC Quality indicators (Beta blockers prescription at discharge in patients with LVEF ≤40%)
时间窗: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on beta blockers.
Adherence to ESC Quality indicators (radial access)
时间窗: From enrollment to 12 months follow-up
Use of radial access in case of invasive strategy for patients with STEMI and NSTEMI
Adherence to ESC Quality indicators (LLA prescription at discharge in STEMI and NSTEMI patients)
时间窗: From enrollment to 12 months follow-up
Proportion of patients discharged from hospital on Lipid Lowering Agents (LLA)
Adherence to ESC Quality indicators (ACEi/ARB/ARNI prescription at discharge in patients with LVEF ≤40%)
时间窗: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on angiotensin converting enzymes inhibitors (ACEi) or angiotensin receptor blockers (ARBs) or angiotensin receptor-neprilysin inhibitor (ARNI)
Adherence to ESC Quality indicators (time to reperfusion in STEMI patients)
时间窗: From enrollment to 12 months follow-up
The time between the initial STEMI diagnosis and arterial access (absolute value) for primary PCI
Adherence to ESC Quality indicators (pre-discharge LVEF evaluation in STEMI and NSTEMI patients)
时间窗: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have an assessment of their left ventricular ejection fraction (LVEF) before hospital discharge
Adherence to ESC Quality indicators (in hospital LDL-c evaluation in STEMI and NSTEMI patients)
时间窗: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have their LDL cholesterol measured during hospitalization
Adherence to ESC Quality indicators (DAPT prescription at discharge in STEMI and NSTEMI patients)
时间窗: From enrollment to 12 months follow-up
Proportion of patients with STEMI and NSTEMI discharged on dual antiplatelet therapy
次要结局
- Cardiovascular and non-cardiovascular events during follow-up(12 months follow-up)